MedinCell begins first Covid-19 clinical study with Ivermectin

MedinCell begins first Covid-19 clinical study with Ivermectin

Source: 
Pharmaceutical Business Review
snippet: 

French clinical-stage pharmaceutical firm MedinCell has commenced the first clinical trial of its Covid-19 prevention program.